Jyong Biotech Ltd. Ordina... (MENS)
NASDAQ: MENS
· Real-Time Price · USD
42.24
-2.50 (-5.59%)
At close: Aug 18, 2025, 3:59 PM
42.70
1.09%
Pre-market: Aug 19, 2025, 04:58 AM EDT
-5.59% (1D)
| Bid | 40 |
| Market Cap | 3.14B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -1056 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 42.71 |
| Volume | 172,507 |
| Avg. Volume (20D) | 238,500 |
| Open | 42.01 |
| Previous Close | 44.74 |
| Day's Range | 40.00 - 45.00 |
| 52-Week Range | 6.01 - 52.29 |
| Beta | n/a |
About MENS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MENS
Website n/a
3 weeks ago · seekingalpha.com
Jyong Biotech's Plant‑Based Pipeline Targets Huge Markets But Risks RemainJyong Biotech develops botanical drugs for urinary disorders. Their lead asset is clearly MCS‑2, which is currently restarting Phase 3 trials after a previous FDA setback. Their pipeline targets large...
